RNU6-1222P

Across TCGA pan-cancer cohorts, RNU6-1222P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-1222P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-1222P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1222P expression acts as an unfavorable survival marker.

KIRP, LGG, and SKCM are the cancer types where RNU6-1222P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.416	0.862	<.001	72	view →
LGG	DFS	Tertile	All	0.140	0.834	<.001	36	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	36	view →
READ	DFS	Tertile	All	0.111	0.799	.001	36	view →
LIHC	OS	Tertile	III,IV	0.270	0.732	.021	27	view →
BLCA	OS	Tertile	IV	0.227	0.603	.012	18	view →
UCEC	DFS	Tertile	All	0.123	0.648	.033	18	view →
LUAD	OS	Tertile	II,III,IV	0.290	0.598	.018	18	view →
LUSC	DFS	Tertile	II,III,IV	0.139	0.663	.027	9	view →
ESCA	DFS	Median	II,III,IV	0.317	0.893	.009	9	view →
STAD	OS	Quartile	IV	0.102	0.534	.009	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-1222P–KIRP (DFS)

Open the KIRP breakdown →